News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
173,973 Results
Type
Article (32766)
Company Profile (13)
Press Release (141194)
Section
Business (53482)
Career Advice (382)
Deals (3353)
Drug Delivery (7)
Drug Development (24712)
Employer Resources (34)
FDA (3437)
Job Trends (3263)
News (82866)
Policy (4268)
Tag
Academia (2423)
Alliances (11229)
Alzheimer's disease (494)
Approvals (3428)
Artificial intelligence (29)
Bankruptcy (19)
Best Places to Work (2730)
Breast cancer (36)
Cancer (307)
Cardiovascular disease (29)
Career advice (352)
Cell therapy (57)
Clinical research (18758)
Collaboration (87)
COVID-19 (1177)
C-suite (69)
Cystic fibrosis (18)
Data (375)
Diabetes (29)
Diagnostics (1645)
Earnings (6406)
Employer resources (31)
Events (17801)
Executive appointments (211)
FDA (3542)
Funding (97)
Gene editing (18)
Gene therapy (46)
GLP-1 (117)
Government (954)
Healthcare (5208)
Infectious disease (1193)
Inflammatory bowel disease (32)
Interviews (42)
IPO (1509)
Job creations (593)
Job search strategy (329)
Layoffs (30)
Legal (690)
Liver cancer (18)
Lung cancer (42)
Manufacturing (21)
Medical device (3054)
Medtech (3055)
Mergers & acquisitions (1858)
Metabolic disorders (78)
Neuroscience (555)
NextGen Class of 2024 (1849)
Non-profit (1752)
Northern California (388)
Obesity (35)
Opinion (27)
People (32329)
Phase I (5939)
Phase II (8565)
Phase III (5724)
Pipeline (84)
Postmarket research (1008)
Preclinical (3123)
Press Release (25)
Radiopharmaceuticals (64)
Rare diseases (51)
Real estate (1296)
Regulatory (2904)
Research institute (1388)
Resumes & cover letters (23)
Southern California (293)
Startups (1192)
United States (2922)
Vaccines (182)
Weight loss (18)
Date
Today (34)
Last 7 days (208)
Last 30 days (780)
Last 365 days (7870)
2024 (7098)
2023 (9581)
2022 (11860)
2021 (13631)
2020 (13175)
2019 (12530)
2018 (9311)
2017 (8969)
2016 (9201)
2015 (10555)
2014 (8068)
2013 (7803)
2012 (7783)
2011 (7839)
2010 (6940)
Location
Africa (268)
Arizona (34)
Asia (10365)
Australia (2595)
California (765)
Canada (253)
China (57)
Colorado (39)
Connecticut (39)
Europe (27560)
Florida (86)
Georgia (26)
Illinois (94)
Indiana (41)
Japan (20)
Maryland (85)
Massachusetts (496)
Michigan (20)
Minnesota (45)
New Jersey (201)
New York (224)
North Carolina (206)
Northern California (388)
Ohio (50)
Pennsylvania (159)
South America (297)
Southern California (293)
Texas (109)
Washington State (87)
173,973 Results for "harvard university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Biotech Bay
NTT Research Funds New Program with Harvard Center for Brain Science
NTT Research, Inc., a division of NTT, announced that the NTT Research Foundation, a 5013 organization, has made a gift to establish the Harvard University Center for Brain Science -NTT Fellowship Program in the new field of Physics of Intelligence.
April 11, 2024
·
6 min read
Press Releases
Harvard Bioscience Announces Third Quarter 2024 Financial Results
November 8, 2024
·
13 min read
Business
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.
May 13, 2024
·
6 min read
Genetown
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
May 23, 2024
·
1 min read
Business
Harvard Bioscience Announces First Quarter 2024 Financial ResultsStrong gross margin performance and focus on efficiency to support ongoing investments in growth
Harvard Bioscience, Inc. announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
10 min read
Genetown
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
Harvard Bioscience, Inc. announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth.
April 9, 2024
·
2 min read
Genetown
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
May 16, 2024
·
1 min read
Business
Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported fourth quarter and full year 2023 financial results.
April 2, 2024
·
9 min read
Business
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Harvard Bioscience, Inc. today announced financial results for the fourth quarter and year ended December 31, 2023.
March 7, 2024
·
13 min read
1 of 17,398
Next
